EUVIMEDOpdag EUVIMED
VergleichsstudieEvaluationsstudieMultizentrische StudieOpen access

Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation

Vlasios Gourgiotis, Charlotte Graham, Kristen Foerster, NHS England Pilot and NHS England Oversight Group, Rebecca C Fitzgerald, Rory Harvey, Danielle L Morris iD

Alimentary Pharmacology & Therapeutics · 2025-03 · 61 (5) · 876-885

DOI: 10.1111/apt.18472 ↗

At a glance

Vergleichsstudie in Alimentary Pharmacology & Therapeutics, published online on 2025-01-10. Written by Vlasios Gourgiotis and 6 co-authors. Institution: Barts Cancer Institute, Queen Mary University of London, London, UK. Major MEDLINE topics: Barrett Esophagus, Gastroesophageal Reflux, Triage. Cited 10 times so far (Crossref); 22 references. The full text is freely available in PubMed Central. Funded by: NHS England.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Acid reflux is a common presentation in primary care leading to a high volume of referrals to endoscopy that are often normal.

Aims

To determine whether a non‐endoscopic capsule sponge biomarker test could triage patients with low‐risk reflux symptoms, reduce endoscopy waiting lists and identify Barrett's oesophagus in a real‐world setting.

Methods

Patients with reflux symptoms on NHS endoscopy waiting lists who were offered a capsule sponge (test group) between February 2021 and August 2022 were included in this national multicentre prospective cohort study and compared with eligible patients on the standard endoscopy pathway (counterfactual group).

Results

Two thousand one hundred seventy patients from 23 hospitals undertook a capsule sponge triage test and submitted follow‐up data, of whom 1694 (78%) were discharged without endoscopy and 476 (22%) were referred for endoscopy. In a detailed subgroup analysis 1411/1549 (92%) attended and successfully swallowed the capsule of whom 307/1411 (21.8%) required endoscopy. Of 111 patients with positive capsule sponge biomarker results who had endoscopy, 19.8% had Barrett's oesophagus. In comparison, in patients with negative sponge biomarkers who were referred for endoscopy due to ongoing symptoms, none had Barrett's oesophagus ( p = 0.0002). Eighty‐two percent surveyed (267/357) were satisfied with the alternative pathway.

Conclusions

Capsule sponge triage is feasible, safe and acceptable. It substantially reduces the endoscopy burden for routine reflux referrals with a favourable diagnostic yield for Barrett's oesophagus. Longer term follow‐up will help to confidently assess the impact of the programme and place of capsule sponge in the diagnostic pathway.

Subjects

MeSH terms (MEDLINE)

Barrett EsophagusGastroesophageal RefluxTriageAdultAgedFemaleHumansMaleMiddle AgedBiomarkersEnglandProspective StudiesReferral and ConsultationState MedicineWaiting Lists

Author keywords

Barrett's oesophagusGERD or GORDbiomarkerscapsule sponge testendoscopynon‐endoscopic test

Substances

Biomarkers

Authors and institutions

  • Barts Cancer Institute, Queen Mary University of London, London, UK.
  • NHS England, England, UK.
  • Early Cancer Insitute, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Bedfordshire Hospitals NHS Foundation Trust, Bedfordshire, UK.
  • Department of Gastroenterology, East and North Hertfordshire NHS Trust, Hertfordshire, UK.

ORCID profiles: Danielle L Morris

Funding

  • NHS England

Cite

APA

Gourgiotis, V., Graham, C., Foerster, K., NHS England Pilot and NHS England Oversight Group, Fitzgerald, R. C., Harvey, R., & Morris, D. L. (2025). Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation. Alimentary Pharmacology & Therapeutics, 61(5), 876-885. https://doi.org/10.1111/apt.18472

Vancouver

Gourgiotis V, Graham C, Foerster K, NHS England Pilot and NHS England Oversight Group, Fitzgerald RC, Harvey R, et al. Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation. Alimentary Pharmacology & Therapeutics. 2025;61(5):876-885. doi:10.1111/apt.18472

BibTeX
@article{Gourgiotis2025,
  author = {Gourgiotis, Vlasios and Graham, Charlotte and Foerster, Kristen and NHS England Pilot and NHS England Oversight Group, NHS England Pilot and NHS England Oversight Group and Fitzgerald, Rebecca C and Harvey, Rory and Morris, Danielle L},
  title = {Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {5},
  pages = {876--885},
  doi = {10.1111/apt.18472}
}
Start for free →